Iron supplement prevents lead-induced disruption of the blood-brain barrier during rat development

Toxicology and Applied Pharmacology

Volumn 219, Issue 1, 2007, Pages 33-41

  Wang, Qiang ^a   Luo, Wenjing ^a   Zheng, Wei ^b   Liu, Yiping ^c   Xu, Hui ^a   Zheng, Gang ^a   Dai, Zhongming ^a   Zhang, Wenbin ^a   Chen, Yaoming ^a   Chen, Jingyuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b PURDUE UNIVERSITY   (United States)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Blood brain barrier; Iron; Lead; Occludin; Tight junction

Indexed keywords

DRINKING WATER; FERROUS SULFATE; IRON; LANTHANUM; LEAD; LEAD ACETATE; OCCLUDIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN DEVELOPMENT; BRAIN TISSUE; CONTROLLED STUDY; ELECTRON MICROSCOPE; EXPOSURE; LEAD POISONING; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; WESTERN BLOTTING;

ANIMALS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BRAIN; DIETARY SUPPLEMENTS; IRON, DIETARY; LANTHANUM; LEAD; MALE; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; NITRIC ACID; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIGHT JUNCTIONS; WATER SUPPLY;

ANIMALIA; RATTUS;

EID: 33846904766     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.11.035     Document Type: Article

References (59)

1. Anderson G.J., and Powell L.W. HFE and non-HFE hemochromatosis. Int. J. Hematol. 76 (2002) 203-207
2. Angle C.R., McIntire M.S., and Brunk G. Effect of anemia on blood and tissue lead in rats. J. Toxicol. Environ. Health 3 (1977) 557-563
3. Azim W., Parveen S., and Parveen S. Comparison of photometric cyanmethemoglobin and automated methods for hemoglobin estimation. J. Ayub. Med. Coll. Abbottabad. 14 (2002) 22-23
4. Balda M.S., Whitney J.A., Flores C., Gonzalez S., Cereijido M., and Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J. Cell Biol. 134 (1996) 1031-1049
5. Bannon I.D., Portnoy M.E., Olivi L., Lees P.S., Culotta V.C., and Bressler J.P. Uptake of lead and iron by divalent metal transporter 1 in yeast and mammalian cells. Biochem. Biophys. Res. Commun. 295 (2002) 978-984
6. Bellinger D.C. Lead. Pediatrics 113 4 Suppl. (2004) 1016-1022
7. Bradbury M.W., and Deane R. Permeability of the blood-brain barrier to lead. Neurotoxicology 14 (1993) 131-136
8. Bradford M.M. A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
9. Bradman A., Eskenazi B., Sutton P., Athanasoulis M., and Goldman L.R. Iron deficiency associated with higher blood lead in children living in contaminated environments. Environ. Health Perspect. 109 (2001) 1079-1084
10. Bressler J., Kim K.A., Chakraborti T., and Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochem. Res. 24 (1999) 595-600
11. Canonne-Hergaux F., Gruenheid S., Ponka P., and Gros P. Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood 93 (1999) 4406-4417
12. Choi J.W., and Kim S.K. Association between blood lead concentrations and body iron status in children. Arch. Dis. Child. 88 (2003) 791-792
13. Corpas I., Benito M.J., Marquina D., Castillo M., Lopez N., and Antonio M.T. Gestational and lactational lead intoxication produces alterations in the hepatic system of rat pups. Ecotoxicol. Environ. Saf. 51 (2002) 35-43
14. Cory-Schlecta D.A., and Schaumburg H.H. Lead, inorganic. In: Spencer P.S., Schaumburg H.H., and Ludolph A.C. (Eds). Experimental and Clinical Neurotoxicology. 2nd ed. (2000), Oxford University, New York 708-720
15. Cory-Slechta D.A., Weiss B., and Cox C. Delayed behavioral toxicity of lead with increasing exposure concentration. Toxicol. Appl. Pharmacol. 71 (1983) 342-352
16. Courtois F., Suc I., Garofalo C., Ledoux M., Seidman E., and Levy E. Iron-ascorbate alters the efficiency of Caco-2 cells to assemble and secrete lipoproteins. Am. J. Physiol.: Gastrointest. Liver Physiol. 279 (2000) G12-G19
17. Davies D.C. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J. Anat. 200 (2002) 639-646
18. Dyatlov V.A., Platoshin A.V., Lawrence D.A., and Carpenter D.O. Lead potentiates cytokine- and glutamate-mediated increases in permeability of the blood-brain barrier. Neurotoxicology 19 (1998) 283-291
19. Ferruzza S., Scacchi M., Scarino M.L., and Sambuy Y. Iron and copper alter tight junction permeability in human intestinal Caco-2 cells by distinct mechanisms. Toxicol. In Vitro 16 (2002) 399-404
20. Flanagan P.R., Hamilton D.L., Haist H.J., and Valberg L.S. Interrelationships between iron and lead absorption in iron-deficient mice. Gastroenterology 77 (1979) 1074-1081
21. Fleming M.D., Trenor C., Su M.A., Foernzler D., Beier D.R., Dietrich W.F., and Andrews N.C. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16 (1997) 383-386
22. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., and Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388 (1997) 482-488
23. Hammad T.A., Sexton M., and Langenberg P. Relationship between blood lead and dietary iron intake in preschool children. A cross-sectional study. Ann. Epidemiol. 6 (1996) 30-33
24. Hirase T., Staddon J.M., Saitou M., Ando-Akatsuka Y., Itoh M., Furuse M., Fujimoto K., Tsukita S., and Rubin L.L. Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell Sci. 110 (1997) 1603-1613
25. Holtzman D., DeVries C., Nguyen H., Olson J., and Bensch K. Maturation of resistance to lead encephalopathy: cellular and subcellular mechanisms. Neurotoxicology 5 (1984) 97-124
26. Huber J.D., Egleton R.D., and Davis T.P. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24 (2001) 719-725
27. Huber J.D., Witt K.A., Hom S., Egleton R.D., Mark K.S., and Davis T.P. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am. J. Physiol.: Heart Circ. Physiol. 280 (2001) H1241-H1248
28. Iavicoli I., Carelli G., Stanek E.J., Castellino N., and Calabrese E.J. Effects of low doses of dietary lead on red blood cell production in male and female mice. Toxicol. Lett. 137 (2003) 193-199
29. Kerper L.E., and Hinkle P.M. Lead uptake in brain capillary endothelial cells: activation by calcium store depletion. Toxicol. Appl. Pharmacol. 146 (1997) 127-133
30. Kevil C.G., Okayama N., Trocha S.D., Kalogeris T.J., Coe L.L., Specian R.D., Davis C.P., and Alexander J.S. Expression of zonula occludens and adherens junctional proteins in human venous and arterial endothelial cells: role of occludin in endothelial solute barriers. Microcirculation 5 (1998) 197-210
31. Kevil C.G., Payne D.K., Mire E., and Alexander J.S. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J. Biol. Chem. 273 (1998) 15099-15103
32. Kim H.S., Lee S.S., Hwangbo Y., Ahn K.D., and Lee B.K. Cross-sectional study of blood lead effects on iron status in Korean lead workers. Nutrition 19 (2003) 571-576
33. Leggett R.W. An age-specific kinetic model of lead metabolism in humans. Environ. Health Perspect. 101 (1993) 598-616
34. Matter K., and Balda M.S. Signalling to and from tight junctions. Nat. Rev., Mol. Cell Biol. 4 (2003) 225-236
35. Moorhouse S.R., Carden S., Drewitt P.N., Eley B.P., Hargreaves R.J., and Pelling D. The effect of chronic low level lead exposure on blood-brain barrier function in the developing rat. Biochem. Pharmacol. 37 (1988) 4539-4547
36. Morgan E.H., and Oates P.S. Mechanisms and regulation of intestinal iron absorption. Blood Cells Mol. Diseases 29 (2002) 384-399
37. Muldoon S.B., Cauley J.A., Kuller L.H., Morrow L., Needleman H.L., Scott J., and Hooper F.J. Effects of blood lead levels on cognitive function of older women. Neuroepidemiology 15 (1996) 62-72
38. Oates P.S., Trinder D., and Morgan E.H. Gastrointestinal function, divalent metal transporter-1 expression and intestinal iron absorption. Pflügers Arch. 440 (2000) 496-502
39. Press M.F. Lead encephalopathy in neonatal Long-Evans rats: morphologic studies. J. Neuropathol. Exp. Neurol. 36 (1977) 169-193
40. Press M.F. Lead-induced permeability changes in immature vessels of the developing cerebellar microcirculation. Acta Neuropathol. (Berl.) 67 (1985) 86-95
41. Ragan H.A. Effects of iron deficiency on the absorption and distribution of lead and cadmium in rats. J. Lab. Clin. Med. 90 (1977) 700-706
42. Robertson I.K., and Worwood M. Lead and iron absorption from rat small intestine: the effect of dietary Fe deficiency. Br. J. Nutr. 40 (1978) 253-260
43. Ruan S., Gu Z., and Yang Y. Energy dispersive X-ray analysis in studying the permeability of blood-brain barrier caused by lead in rats. Zhonghua Yufang Yixue Zazhi 33 (1999) 107-109 (in Chinese)
44. Rubin L.L., and Staddon J.M. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22 (1999) 11-28
45. Schwartz B.S., Stewart W.F., Bolla K.I., Simon P.D., Bandeen-Roche K., Gordon P.B., Links J.M., and Todd A.C. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology 55 (2000) 1144-1150
46. Six K.M., and Goyer R.A. The influence of iron deficiency on tissue content and toxicity of ingested lead in the rat. J. Lab. Clin. Med. 79 (1972) 128-136
47. Stollery B.T. Reaction time changes in workers exposed to lead. Neurotoxicol. Teratol. 18 (1996) 477-483
48. Struzynska L., Walski M., Gadamski R., Dabrowska-Bouta B., and Rafalowska U. Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity. Mol. Chem. Neuropathol. 31 (1997) 207-224
49. Sundstrom R., Muntzing K., Kalimo H., and Sourander P. Changes in the integrity of the blood-brain barrier in suckling rats with low dose lead encephalopathy. Acta Neuropathol. (Berl.) 68 (1985) 1-9
50. Tallkvist J., Bowlus C.L., and Lonnerdal B. Functional and molecular responses of human intestinal Caco-2 cells to iron treatment. Am. J. Clin. Nutr. 72 (2000) 770-775
51. Trinder D., Oates P.S., Thomas C., Sadleir J., and Morgan E.H. Localisation of divalent metal transporter 1 (DMT1) to the microvillus membrane of rat duodenal enterocytes in iron deficiency, but to hepatocytes in iron overload. Gut 46 (2000) 270-276
52. Trocha S.D., Kevil C.G., Mancini M., and Alexander J.S. Organ preservation solutions increase endothelial permeability and promote loss of junctional proteins. Ann. Surg. 230 (1999) 105-113
53. Wright R.O., Hu H., Maher T.J., Amarasiriwardena C., Chaiyakul P., Woolf A.D., and Shannon M.W. Effect of iron deficiency anemia on lead distribution after intravenous dosing in rats. Toxicol. Ind. Health 14 (1998) 547-551
54. Wright R.O., Shannon M.W., Wright R.J., and Hu H. Association between iron deficiency and low-level lead poisoning in an urban primary care clinic. Am. J. Public Health 89 (1999) 1049-1053
55. Zhao Q., Slavkovich V., and Zheng W. Lead exposure promotes translocation of protein kinase C activity in rat choroid plexus in vitro, but not in vivo. Toxicol. Appl. Pharmacol. 149 (1998) 99-106
56. Zheng W., Perry D.F., Nelson D.L., and Aposhian H.V. Protection of cerebrospinal fluid against toxic metals by the choroid plexus. FASEB J. 5 (1991) 2188-2193
57. Zheng W., Shen H., Blaner W.S., Zhao Q., Ren X., and Graziano J.H. Chronic lead exposure alters transthyretin concentration in rat cerebrospinal fluid: the role of the choroid plexus. Toxicol. Appl. Pharmacol. 139 (1996) 445-450
58. Zheng W., Aschner M., and Ghersi-Egea J.F. Brain barrier systems: a new frontier in metal neurotoxicological research. Invited Review. Toxicol. Appl. Pharmacol. 192 (2003) 1-11
59. Zoller H., Koch R.O., Theurl I., Obrist P., Pietrangelo A., Montosi G., Haile D.J., Vogel W., and Weiss G. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 120 (2001) 1412-1419